Understanding Diseases, Financing Drugs: A Need for Innovative Strategies

The Swiss Biotech Association and swissnex San Francisco invite interested parties to a networking event during “Biotech Week.” If you are a biotech company, investor, start-up, spin-off, part of the swissnex or SBA communities, or an academic-industry liaison, this might be for you.

11 Jan 2011 from 6:00 PM to 9:00 PM Pacific Standard Time (UTC - 8)

Archives:

View Photos from this event

The Swiss Biotech Association (SBA) represents more than 200 small and medium-sized enterprises active in all areas of biotechnology, a robust Swiss industry. Join representatives from this sector to discuss new ways of financing biotech ventures, a necessary step in sustaining and expanding the biotech business.

Program

6:00 pm	Opening and Welcome by Domenico Alexakis, Swiss Biotech Association and Christian Simm, swissnex San Francisco
6:15 pm	A next generation business model targeting the important orphan drug market – Frank Grossmann, CEO, orphanbiotec AG
6:30 pm	An open-source bioscience technology company delivering a pipeline for Rare Diseases – Paolo Bassanini, Investor & External Relations, mondoBIOTECH
6:45 pm	A start-up company targeting cancer-initiating cells, the roots of cancer – Daniel Leutenegger, CEO & Co-Founder, Stemergie Biotechnology SA
7:00 pm	Alternative Strategies to Finance Drug Development – Roundtable discussion moderated by Alexander Fries, President, Ecosystem Ventures LLC
7:30 pm	Networking Reception

Personal tools

Sections

Understanding Diseases, Financing Drugs: A Need for Innovative Strategies

Program